Roivant anticipates $950M Moderna payment in July as it outlines 2H 2026 mosliciguat and IMVT-1402 readouts (NASDAQ:ROIV)
· seekingalpha.com
Roivant (ROIV) Q4 2025 earnings call highlights: IMVT-1402 RA data, mosliciguat PH-ILD updates, brepocitinib launch timeline & Moderna settlement—read now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...